INS and Insulin resistance: Increased production of proinflammatory cytokines is known to induce insulin resistance (a decreased efficacy of insulin on glucose utilization in insulin-sensitive tissues, including muscles, adipose tissue, the liver, and the brain), which exacerbates metabolic disturbances, further increasing the level of inflammation [14,15].